Menu

• Ask a Health Expert about PULMONARY SEPSIS
• Post Your Side Effect related to PULMONARY SEPSIS
• PULMONARY SEPSIS and FDA Warnings
• PULMONARY SEPSIS in Patients Wiki
• Report PULMONARY SEPSIS in Drug Side Effect Survey

PULMONARY SEPSIS side effect

What is PULMONARY SEPSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Carboplatin Side Effects Report #5452645-8
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Sept 13, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary sepsis, . CARBOPLATIN dosage: unknown. During the same period patient was treated with CELECOXIB, DOCETAXEL. Patient was hospitalized. Patient died on 03/25/2007.

Tysabri Side Effects Report #5679736-0
TYSABRI problem was reported by a Health Professional from GREECE on Mar 18, 2008. Male patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: pneumonia, pulmonary sepsis, septic shock, transaminases increased, . TYSABRI dosage: unknown. Patient was hospitalized. Patient died on 02/18/2008.

Enbrel Side Effects Report #5629588-X
Health Professional from UNITED KINGDOM reported ENBREL problem on Feb 07, 2008. Female patient, 69 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, pulmonary sepsis, . ENBREL dosage: unknown. During the same period patient was treated with PREDNISOLONE, OMEPRAZOLE, DICLOFENAC, METHOTREXATE. Patient died on 01/04/2008.

Tysabri Side Effects Report #5679736-0
TYSABRI problem was reported by a Health Professional from GREECE on Mar 18, 2008. Male patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: pneumonia, pulmonary sepsis, septic shock, transaminases increased, . TYSABRI dosage: unknown. Patient was hospitalized. Patient died on 02/18/2008.


Kaletra Side Effects Report #5612842-5
Consumer or non-health professional from CHILE reported KALETRA problem on Jan 30, 2008. Female patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cachexia, hiv infection cdc group iii, pulmonary sepsis, pyrexia, respiratory distress, respiratory failure, treatment noncompliance, . KALETRA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, TENOFOVIR DISOPROXIL FUMARATE. Patient died on 01/22/2008.